Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry
暂无分享,去创建一个
S. Sihag | N. Schultz | M. Berger | K. Arora | Z. Stadler | G. Ku | Y. Kemel | Laura Tang | V. Strong | S. Vardhana | Miseker E. Abate | Teng Fei | A. Maio | C. Vanderbilt | H. Walch | M. Brennan | Joseph Schmeltz | Harrison M Drebin | Shoji Shimada | Ping Gu | Harrison M. Drebin
[1] N. Schultz,et al. Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort. , 2022, Cancer discovery.
[2] M. Gonen,et al. A Novel Microbiome Signature in Gastric Cancer , 2022, Annals of surgery.
[3] K. Pradhan,et al. The Genomics of Colorectal Cancer in Populations with African and European Ancestry , 2022, Cancer discovery.
[4] L. K. Teixeira,et al. Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability , 2021, Frontiers in Cell and Developmental Biology.
[5] David R. Jones,et al. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients , 2021, Cell.
[6] Yingtai Chen,et al. Regional and racial disparity in proximal gastric cancer survival outcomes 1996–2016: Results from SEER and China National Cancer Center database , 2021, Cancer medicine.
[7] D. Durocher,et al. CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition , 2021, Nature.
[8] David R. Jones,et al. Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways , 2021, Clinical Cancer Research.
[9] Allison P. Heath,et al. The NCI Genomic Data Commons , 2021, Nature Genetics.
[10] Laura H. Tang,et al. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies. , 2020, JAMA surgery.
[11] M. Ladanyi,et al. Abstract 6095: Unique tumor microbiome in microsatellite instability high (MSI-H) colon carcinoma , 2020 .
[12] S. Raman,et al. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[13] Jeffrey S. Damrauer,et al. Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer , 2020, Cancer Cell.
[14] Daigo Hashimoto,et al. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. , 2020, The New England journal of medicine.
[15] Kyoung-Mee Kim,et al. CCNE1 amplification is associated with liver metastasis in gastric carcinoma. , 2019, Pathology, research and practice.
[16] Laura H. Tang,et al. Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype , 2019, The American journal of surgical pathology.
[17] M. Mazumdar,et al. Stage‐matched survival differences by ethnicity among gastric cancer patients of Asian ancestry treated in the United States , 2019, Journal of surgical oncology.
[18] T. Rebbeck,et al. Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers. , 2018, Cancer cell.
[19] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[20] Jonathan M. Hernandez,et al. Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer , 2018, Annals of Surgical Oncology.
[21] Steven J. M. Jones,et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. , 2018, Cell.
[22] Michael T. Zimmermann,et al. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas , 2018, Cell reports.
[23] M. Porembka,et al. Gastric Cancer: Recent Molecular Classification Advances, Racial Disparity, and Management Implications. , 2018, Journal of oncology practice.
[24] Laura H. Tang,et al. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients , 2017, Annals of surgery.
[25] P. Kantoff,et al. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing , 2017, JAMA.
[26] Donavan T. Cheng,et al. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing , 2017, BMC Medical Genomics.
[27] Moriah H Nissan,et al. OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.
[28] J. Ajani,et al. Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer , 2017, Annals of Surgical Oncology.
[29] S. Ikeda,et al. Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors. , 2016, JAMA oncology.
[30] G. Spolverato,et al. Stage-Specific Prognostic Effect of Race in Patients with Resectable Gastric Adenocarcinoma: An 8-Institution Study of the US Gastric Cancer Collaborative. , 2016, Journal of the American College of Surgeons.
[31] C. Yeh,et al. Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients , 2016, Oncotarget.
[32] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[33] Marc Peeters,et al. Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer , 2015, Clinical Cancer Research.
[34] Donavan T. Cheng,et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.
[35] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[36] A. Bilchik,et al. Race Influences Stage-specific Survival in Gastric Cancer , 2015, The American surgeon.
[37] S. Brower,et al. Race/Ethnicity Is Predictive of Lymph Node Status in Patients with Early Gastric Cancer , 2014, Journal of Gastrointestinal Surgery.
[38] Steven J. M. Jones,et al. Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.
[39] H. Liang,et al. Clinical significance of lymph node metastasis in gastric cancer. , 2014, World journal of gastroenterology.
[40] Kai Ye,et al. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data , 2014, Bioinform..
[41] S. Gabriel,et al. Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.
[42] Su Jin Lee,et al. Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients , 2013, Investigational New Drugs.
[43] N. Hu,et al. Comparison of Global Gene Expression of Gastric Cardia and Noncardia Cancers from a High-Risk Population in China , 2013, PloS one.
[44] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[45] Carla Mattos,et al. A comprehensive survey of Ras mutations in cancer. , 2012, Cancer research.
[46] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[47] M. Ryu,et al. Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum , 2012, British Journal of Cancer.
[48] Adam M. Phillippy,et al. Interactive metagenomic visualization in a Web browser , 2011, BMC Bioinformatics.
[49] Laura H. Tang,et al. Molecular Classification of Gastric Cancer: A New Paradigm , 2011, Clinical Cancer Research.
[50] David H. Alexander,et al. Fast model-based estimation of ancestry in unrelated individuals. , 2009, Genome research.
[51] Chun Meng Song,et al. Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. , 2009, European Journal of Cancer.
[52] David R. Jones,et al. Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer. , 2018, Cancer discovery.
[53] W. Bossert,et al. The Measurement of Diversity , 2001 .